Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event
Sponsor
AstraZeneca (Industry)
Overall Status
Completed
CT.gov ID
NCT01395550
Collaborator
(none)
88
5.9
Study Details
Study Description
Brief Summary
AstraZeneca was interested in knowing how Cardiologists and Physicians treat patients who have suffered a cardiovascular event.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
88 participants
Time Perspective:
Retrospective
Official Title:
Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event.
Study Start Date
:
Jan 1, 2010
Actual Primary Completion Date
:
Jul 1, 2010
Actual Study Completion Date
:
Jul 1, 2010
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- All patients who has experienced cardiovascular events
Exclusion Criteria:
- Patients with no cardiovascular events.
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- AstraZeneca
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT01395550
Other Study ID Numbers:
- NIS-CZA-XXX-2011/1
First Posted:
Jul 15, 2011
Last Update Posted:
Aug 30, 2011
Last Verified:
Aug 1, 2011